✦ LIBER ✦

Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer: Cervical cancer immunotherapy study group

✍ Scribed by Kiichiro Noda; Kensaku Teshima; Kunio Tekeuti; Kazuo Hasegawa; Kin-ya Inoue; Kazuhiko Yamashita; Isamu Sawaragi; Tokuro Nakajima; Eisei Takashima; Masanori Ikeuchi; Kaoru Sekiba; Hiroyuki Okuda; Motohiko Ichijo; Tsuneo Saito; Mitsuru Ozawa; Hiroyuki Tamura; Tsutomu Chihara; Kazuo Kuzuya; Masami Ozaki; Minoru Inagaki; Suketami Tominaga

Book ID: 119053096
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 568 KB
Volume: 35
Category: Article
ISSN: 0090-8258
DOI: 10.1016/0090-8258(89)90081-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunotherapy using the streptococcal pr

Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group

✍ K Noda; K Teshima; K Tekeuti; K Hasegawa; K-Y Inoue; K Yamashita; I Sawaragi; T 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Immunotherapy using the streptococcal pr

Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group

✍ K Noda; K Teshima; K Tekeuti; K Hasegawa; K-Y Inoue; K Yamashita; I Sawaragi; T 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Immunotherapy using the streptococcal pr

Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer. Cervical Cancer Immunotherapy Study Group

✍ K Noda; K Teshima; K Tekeuti; K Hasegawa; K-Y Inoue; K Yamashita; I Sawaragi; T 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Immunotherapy using the streptococcal pr

Immunotherapy using the streptococcal preparation OK-432 for the treatment of uterine cervical cancer

✍ CERVICAL CANCER IMMUNOTHERAPY STUDY GROUP 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

The effectiveness of immunotherapy using a streptococcal preparation, OK-432, was evaluated for cervical cancer. The 382 eligible patients were stratified by presence/absence of surgical operation and clinical stage, and then, in each stratum, were randomly divided into two groups: an O K 4 3 2 trea

Clinical value of immunotherapy for lung

Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432

✍ Yoh Watanabe; Takashi Iwa 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Locoregional immunotherapy of malignant

Locoregional immunotherapy of malignant effusion from colorectal cancer using the streptococcal preparation OK-432 plus Interleukin-2

✍ Yamaguchi, Y; Miyahara, E; Ohshita, A; Kawabuchi, Y; Ohta, K; Shimizu, K; Minami 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 227 KB